A 50-year-old woman was admitted to the Accident & Emergency department of Baqiyatallah hospital in Tehran (Iran), with symptoms of fever, dyspnoea, dry cough, and fatigue for the past 4 days.

At physical examination, she had enhanced body temperature (38.1 °C), a heart rate of 100 b.p.m., a respiratory rate of 22 breaths/min, and O~2~ saturation of 92%. Laboratory tests revealed an increased white blood cell count (WBC = 13.5 × 10^3^/μL), increased platelets (PLT = 475× 10^3^/μL), polynuclear (80%); partial thromboplastin time (PTT = 5 s), PT~Lab~/INR~Lab~ (=1.31 s); prothrombin test (PT = 18.2 s); and D-dimer (10 ng/mL). Further elevated values were found for C-reactive protein (CRP = 30.3 mg/L), erythrocyte sedimentation rate (ESR = 57 mm/h); serum glutamic-pyruvic transaminase (SGPT = 108 μL); lactate dehydrogenase (LDH = 983μL); and amylase serum (278 μL). Reverse transcription--PCR for COVID-19 was positive and the patient was given oxygen and treated with hydroxychloroquine, dimenhydrinate, and naproxen.
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On day 2 after admission, a chest CT scan without contrast evidenced bilateral diffuse multiple patchy and subpleural consolidations with left pleural effusion---radiological findings consistent with COVID-19 pneumonia (*Panel A*). On day 3 following admission, the patient suddenly developed severe dyspnoea, with O~2~ saturation decreasing to 74%. A chest computed tomography angiography (CTA) was performed, which revealed a large saddle pulmonary embolism in the main pulmonary artery (MPA), right pulmonary artery (RPA), and left pulmonary artery (LPA) (*Panel B*). From day 3 of hospitalization, the patient received anticoagulation therapy with heparin and antithrombotic treatment.

The patient remained in hospital for a further 7 days before being discharged in stable condition, with O~2~ saturation increased to 98%, body temperature of 37.2 °C, negative PCR, and normal laboratory tests.
